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Abstract 
Membrane transport proteins are the molecular gatekeepers that regulate the movement 
of chemicals into and out of every cell of every living organism.
1
 In this study, a 
cheminformatics approach was taken to predict the substrate and inhibitory activities of 14 major 
human intestinal transporters using quantitative structure-activity relationship (QSAR) models 
built from 56 datasets. Dataset compounds were represented using CDK or Dragon descriptors 
and modeled using random forests (RF), support vector machines (SVM), and k-nearest 
neighbors (kNN). In all, 274 predictors passed all cut-offs. The predictive power of these 
predictors, as quantified by the external coefficient of determination (R
2
) of regression predictors 
and correct classification rate (CCR) of classification predictors, was analyzed for correlations 
with characterizing data of the original datasets. Dataset size, represented by the logarithm of the 
cardinality; a modelability index (MODI), defined previously for binary datasets and extended to 
continuous datasets here; and the homology group of the represented transporter were each found 
to have statistically significant effects on predictive power. However, true validation of QSAR 
predictors requires additional laboratory experimentation. 
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Abbreviations 
ABC ATP-Binding Cassette superfamily of 
proteins 
MRP1-5 Multidrug Resistance- associated Proteins 
1-5 
AD Applicability Domain NBD Nucleotide-Binding Domain 
ASBT Apical Sodium-dependent Bile acid 
Transporter 
NTCP Sodium-Taurocholate Cotransporting 
Polypeptide 
ATP Adenosine TriPhosphate OATP2B1 Organic Anion Transport Protein 2B 1 
BCRP Breast Cancer Resistance Protein OCT1 Organic Cation Transporter 1 
BSEP Bile Salt export Pump PEPT1 PEPtide Transporter 1 
CAS Chemical Abstract Services QSAR Quantitative Structure- Activity Relationship 
CCR Correct Classification Rate R2 Coefficient of Determination 
CDK Chemistry Development Kit RF Random Forest 
GA Genetic Algorithm SA Simulated Annealing 
IC50 Half maximal Inhibitory Concentration SDF Structure Data Format 
kNN k-Nearest Neighbor SLC SoLute Carrier family of proteins 
MCT1 MonoCarboxylate Transporter 1 SMILES Simplified Molecular Input Line Entry 
Specification 
MDR1 MultiDrug Resistance Protein 1 SVM Support Vector Machines 
MODI MODelability Index TMD TransMembrane Domain 
 
Glossary of Terms 
Amino Acids the building blocks of proteins Homology the degree of conservation in 
amino acid sequences 
Auto Scaling normalization by standard 
deviation 
In silico conducted in simulation 
Chemical 
Descriptors 
quantified descriptions of the 
salient aspects of a compound 
In vitro conducted in laboratory 
setting 
Cheminformatics the application of information 
techniques to chemical data 
In vivo conducted in biological 
system 
Chemistry space the set of all energetically stable 
compounds Inhibitor 
a chemical that blocks a 
protein's active site 
Chirality asymmetry such that the molecule 
is different from its mirror image 
Pharmacophore abstract description of 
features of an active site 
Combinatorial 
chemistry 
chemical synthetic methods that 
produce entire compound libraries 
from a single process 
Range Scaling normalization by the range of 
values 
Electrochemical 
potential 
the combined effects of 
concentration and electrical 
potential 
Substrate a chemical that binds to a 
protein's active site 
High-throughput 
screening 
robotic or otherwise automated 
screening methods 
Transportome the set of all expressed 
genes corresponding to 
membrane transport 
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Background 
Major Human Transporters 
Drug resistance is mediated by 
nearly 600 identified human transport 
proteins, and it is assumed that at least 5% 
(>2000) of human genes are transport-
related.
1-3
 These transporters largely 
determine drug resistance by absorbing 
from and expelling chemicals into the 
intestines. Membrane transporters are the 
protein doorways responsible for 
facilitating and regulating the movement 
of both biological and pharmaceutical 
chemicals across the cell membrane.
1
 
Transporters may move chemicals into 
(importers) or out of (exporters) the cell 
and to or from the intestine (apical side) or bloodstream (basal side). Individual transporter-
doorways, however, are unlocked by and translocate only a specific profile of chemical-keys 
called substrates. In addition, chemicals may act as inhibitors by preventing the transporter from 
moving substrates. Determining the factors that dictate how a drug interacts with major human 
transport proteins is a critical challenge for drug discovery. 
The difficulty in predicting drug resistance, however, is compounded by the sheer 
complexity of the individual transporters. P-glycoprotein (MDR1) is the archetypal human ABC 
transporter, being the most medically relevant and well-studied. MDR1, Figure 1, is composed of 
1280 amino acids (170 kDa) arranged as a single polypeptide.
2
 Although the corresponding gene 
has been mapped, the crystal structure observed, and the amino acid sequence recorded, 
determining the actual mechanism of poly-specific substrate selection is still a major challenge 
for current bioinformatic techniques.
4
 Alternative methods in the field of cheminformatics 
attempt to predict the interaction between substrate and protein without explicitly modelling the 
transporter active site or the mechanism of selection and transport.
6
 
Figure 1. Crystallographic structure of mouse MDR3 
protein illustrating the tremendous complexity of 
membrane transport proteins. The protein is rainbow 
colored from blue (C-terminus) to red (N-terminus). 
Approximate positioning of the extracellular (blue) 
and cytoplasmic (red) faces of the cell membrane is 
identified by the overlaid lines.
5 
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In this study, we look at members of two major transporter families: the ATP-binding 
cassette (ABC) superfamily and the solute carrier (SLC) group. Collectively, these groups 
include the majority of identified proteins that contribute to drug resistance and susceptibility, 
and understanding their biological differences may help explain differences in our ability to 
predict their behavior. 
ATP-Binding Cassette (ABC) Superfamily 
The ABC superfamily of transporters is fundamental to life as it evolved on Earth; 
members are believed to be present in every cell of every living organism.
2
 All ABC transporters 
have two distinct substructures: a transmembrane domain (TMD, a portion of the protein that 
tunnels through the cell membrane) and cytosolic nucleotide binding domain (NBD). ABC 
proteins actively transport substrates through a series of conformational changes in the TMD that 
are initiated by the binding and hydrolysis of adenosine triphosphate (ATP, the cell’s energy 
molecule) to the NBD. Although the NBD is very similar in all ABC transporters, the TMD vary 
widely, corresponding to variations in compatible substrates. 
Solute Carrier (SLC) Group 
In contrast to the evolutionary relatedness of ABC transporters, membership in the SLC 
group is functional, encompassing all families of transmembrane solute transporters that are not 
primary active transporters, ion channels, nor water channels. Accordingly, different SLC 
subfamilies exhibit little structural similarity, also referred to has homology.
3
 
Mechanisms of Transport 
Membrane transporters form doorways through the cell membrane and operate by one of 
three means: 
 Passive transporters allow substrates to move naturally across the membrane from 
regions of high electrochemical potential to regions of low potential. This flow down an 
electrochemical gradient is energetically favorable and requires no additional energy. 
 Primary active transporters are molecular motors that utilize an energy source, usually 
ATP hydrolysis, to drive the movement of substrate. 
 Secondary active transporters are molecular turbines that couple the movement of two 
substrates simultaneously. The flow of one substrate down its gradient is used to power 
the movement of the other such that the overall energy change is still favorable. 
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ABC proteins undergo primary active transport while the SLC group includes both passive and 
secondary active transporters. 
Cheminformatics 
Although the intersection of chemistry and informatics had been established by the mid-
1960s, the term “cheminformatics” was coined by F. K. Brown in 1998 as  
“the mixing of those information resources to transform data into information and 
information into knowledge for the intended purpose of making better decisions 
faster in the area of drug lead identification and optimization.”7,8  
One year later, at the August 1999 meeting of the American Chemical Society, G. Paris 
broadened to the term to  
“[encompass] the design, creation, organization, management, retrieval, analysis, 
dissemination, visualization, and use of chemical information.”6  
The new nomenclature was a symptom of the exploding interest in the field during the 1990s 
brought about both by advances in synthetic techniques and increases in computational power. In 
particular, the concurrent developments of combinatorial chemical synthesis and high-throughput 
screening allowed chemists to collect data hundreds of thousands times faster than before, the 
quantity of which conventional analytical techniques were simply unable to manage.
8-10
 
In particular, cheminformatics seeks to reduce the time and capital costs of drug 
discovery by better identifying potential candidates earlier in silico. Current drug discovery 
techniques require an estimated fifteen-years and nearly two billion US dollars to bring a new 
drug into the market.
6,11
 These costs are due to the immensity of the chemistry space as well as 
the rigor of clinical trials. Computational techniques, however, are relatively fast and cheap and 
can be employed to reduce the number of exploratory assays and studies necessary.
12-14
 
Molecular Representation 
Molecules are complex real-world objects. Even 3-dimensional topography models are 
little more than illustrative simplifications of what are in reality infinite fields of electron density 
associating infinitesimal points of mass and charge. Although many standards exist in practice, 
the task of representing molecules in silico is neither trivial nor complete. A database of 
molecules may be queried using the accepted common name or a unique registry number 
assigned by the Chemical Abstracts Services (CAS). More informative representations reference 
the chemical structure explicitly: the International Union of Pure and Applied Chemistry               
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Figure 2. Standard cheminformatic representations for aspirin.
6 
Name Representation 
Common Name Aspirin 
Synonyms 
Acetylsalicylic acid, Ecotrin, Acenterine, Acylpyrin, Polopyryna, Acetophen, 
Acetosal, Aspergum 
Empirical Formula C9H8O4 
2D Structure 
 
IUPAC Name 2-Acetoxybenzoic acid 
CAS Registry Number 50-78-2 
SMILES CC(=O)OC1=CC=CC=C1C(=O)O 
InChl 1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12) 
Connection Table (SDF) 
Aspirin 
  Comment Line 
 
21 21  0  0  0  0  0  0  0  999 V2000 
   6.3301   -0.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0 
   4.5981   -1.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0 
   6.3301   -1.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0 
   5.4641   -2.0600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0 
   2.0000   -0.0600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0 
   5.4641   -0.0600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0 
   4.5981   -0.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0 
   4.5981    1.4400    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0 
   2.8660   -1.5600    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0 
   6.3301    1.4400    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0 
   5.4641    0.9400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0 
   2.8660   -0.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0 
   3.7321   -0.0600    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0 
   6.3301    2.0600    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0 
   6.8671   -0.2500    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0 
   4.0611   -1.8700    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0 
   6.8671   -1.8700    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0 
   5.4641   -2.6800    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0 
   2.3100    0.4769    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0 
   1.4631    0.2500    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0 
   1.6900   -0.5969    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0 
 6  7  2  0  0  0  0 
 1  6  1  0  0  0  0 
 6 11  1  0  0  0  0 
 2  7  1  0  0  0  0 
 7 13  1  0  0  0  0 
 1  3  2  0  0  0  0 
10 11  1  0  0  0  0 
 8 11  2  0  0  0  0 
 2  4  2  0  0  0  0 
12 13  1  0  0  0  0 
 5 12  1  0  0  0  0 
 9 12  2  0  0  0  0 
 3  4  1  0  0  0  0 
 1 15  1  0  0  0  0 
 2 16  1  0  0  0  0 
 3 17  1  0  0  0  0 
10 14  1  0  0  0  0 
 4 18  1  0  0  0  0 
 5 19  1  0  0  0  0 
 5 20  1  0  0  0  0 
 5 21  1  0  0  0  0 
M  END 
$$$$ 
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(IUPAC) has defined explicit nomenclature standards, Simplified Molecular Input Line Entry 
Specification (SMILES) defines rules for describing molecular structure using an ASCII string, 
and the Structure Data Format (SDF) standards are the most commonly used graph-based 
representation.
6
 Figure 2 illustrates several standard representations for aspirin. 
The structure itself is usually not useful for analysis, so descriptors are generated from 
the structural representation. Molecular descriptors are quantified features that describe the 
salient aspects of the compound. Both open-source, e.g. CDK, and privately licensed, e.g. 
Dragon, descriptor generators exist with their own individual sets of descriptors.
6
 There are two 
primary classes of descriptors. Information-based descriptors encapsulate the structure of the 
compound and include descriptors for the molecular weight, the number of rotatable bonds, and 
Kier shape indices. Knowledge-based descriptors are calculated using known models and include 
estimates of the polarity in different regions of the compound. The Dragon descriptor set is much 
larger than CDK (2489 v. 202) and includes many more esoteric and hyper-specific descriptors, 
e.g. the frequency of carbon-fluorine atom pairs exactly 10 bonds apart. In general, there is a 
trade-off between interpretability and predictive usefulness.
13
 
QSAR Modeling 
Quantitative structure-activity relationship (QSAR) modelling may be described as the 
use of computational, analytical, and statistical methods to accurately and reliably predict or 
explain the properties or activities of chemical compounds provided only their structure.
15
 
Chemical activity can be defined as any quantifiable and observable behavior. It may be a 
classification (e.g. substrate or not), a regression (e.g. the rate of transport through a membrane), 
or a categorization into an ordered set of classes (e.g. highly active, active, or inactive).
16
 
As early as 1869, Alexander Crum Brown and Thomas Richard Fraser proposed that a 
molecule’s activity can be defined as a mathematical function of its structure.6 Furthermore, the 
structure-activity relationship hypothesis states that similar compounds possess similar 
properties. Unfortunately, chemical similarity and diversity are oftentimes extremely difficult to 
define, and different measures of similarity may be relevant when considering different 
activities. QSAR modeling attempts to quantify a structure-activity relationship such that it may 
be used to identify priority compounds for experimental validation. 
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        The predictive QSAR modeling workflow presented in Figure 3 has been adapted from 
Tropsha 2010.
15
 The input to the QSAR workflow is always a dataset of compounds with 
experimentally confirmed chemical activities. Thus the quality of a QSAR predictor is 
fundamentally reliant on the quality of the experimental values and an accurate understanding 
and representation of the chemical structures. It is critical to curate the chemical dataset to ensure 
accurate structures and to remove any compounds that may not be informative to the model. If 
chirality-sensitive descriptors are not employed, all pairs of mirror images will be represented as 
duplicates; one must be removed, and any variance in their activities must be reconciled. In 
addition, any compounds should be removed that cannot be handled by current techniques, 
including organometallic complexes, inorganic compounds, salts, and mixtures.
15
 
        Any number of supervised learning techniques may then applied to the curated dataset to 
construct the predictor, but the workflow remains the same.
15
 Firstly the dataset must be divided 
Figure 3. Predictive QSAR modeling workflow.
 15 
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into modeling and external sets. Usually many models are constructed from the modelling set, 
and the best models, as identified by some internal evaluation, are consolidated to form the 
predictor. To avoid overfitting, training is conducted using only the modelling set, and the 
external set is used to validate the predictor.
17
 By considering the distribution of compounds, an 
applicability domain (AD) is applied to each model as well as the overall predictor that defines 
the subspace of the chemistry space for which the model has been validated. 
        Although there is a precedent for regulation based solely on predictive modelling,
18
 a 
predictor should ideally be subject to laboratory validation. In silico high-throughput screening 
of the predictor on compound databases will identify additional compounds with activities of 
interest. The activities of some of these compounds should be determined experimentally to 
further validate the predictor.
15
 
Modeling Major Human Transporters 
        The human transportome consists of the subset of the proteome devoted to membrane 
transporters. Recently, there have been several large-scale efforts to collect and organize the ever 
increasing amount of transportome data available.
19-23
 Yet, until very recently, there has been 
little effort to model this substrate data with the corresponding explicit molecular structures.
1
 In 
this study, 56 datasets comprised of 10,407 activity values corresponding to the interaction 
between 3,906 unique chemical compounds and 14 transporters were curated, characterized, and 
modeled using multiple QSAR algorithms. The quality of the QSAR predictors was analyzed to 
elucidate correlations with the chemical, biological, and numerical characters of the datasets. 
Materials and Methods 
Dataset Creation and Curation 
 Chemical-transporter interaction data were collected and curated by the Molecular 
Modeling Lab in the Eshelman School of Pharmacy at the University of North Carolina at 
Chapel Hill. Data were extracted from multiple publically available sources and consolidated 
into 56 datasets.
19-23
 Equivalent records were compared and reconciled to form a single, 
harmonious database. Classification datasets were constructed by combining reports of substrate 
or inhibitory activity. Accordant reports were assigned values of 0 or 1, and ambiguous 
chemicals were not included. Inhibitor classification is defined at a specified threshold 
concentration for each dataset. Binding affinities are included as the negative log of either the 
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Michaelis-Menten constant of transportation (pKm, the relative concentration of substrate needed 
to transport at a rate half of the maximum) or of the half maximal inhibitory concentration 
(pIC50, the relative concentration of inhibitor needed to reduce the rate of transport by half).  In 
addition, datasets of pIC50 values are included for both general and specific hot ligands (the 
substrate whose transport is being inhibited).   
 Chemical structures were standardized by the Molecular Modeling Lab using 
PipelinePilot ver.6.15 (Accelrys) and the Standardizer module (ChemAxon).
1
 Organometallic 
and poorly defined compounds were excluded from the database. In addition, polymers, 
identified as extreme molecular weight outliers, were also excluded. Remaining compounds were 
standardized and translated into their predominant and neutral form. The final curated database is 
available on Chembench.
26
 The full, detailed process for data collection and curation has been 
previously described by Sedykh et al.
1
 
Dataset Characterization 
 The 56 datasets were preliminarily 
characterized by their relevant transporter and 
by the parameters of the activity reported (see 
Tables 6 and 7 of the appendix). A summary 
of the number of compounds in the datasets is available in Table 1. Twenty-five datasets 
comprised of continuous values, and 31 contained binary assignments. Eighteen datasets 
reported substrate activity, and 38 reported inhibitory activity (see Figure 5).  
 Transporters were also characterized by 
the physiological role in the human body (see 
Table 8 of the appendix and Figure 4).
24
 In all, 
14 transporters from the ABC and SLC groups 
are represented. Their membrane location, 
direction of flow, subfamily, and archetypal 
substrate are also reported and were included in 
the statistical analysis. 
Table 1. Summary of dataset cardinality. 
Activity Type Max Min Mean St. Dev. 
Classification 
(N = 31) 
1585 34 228.3 313.7 
Continuous 
(N = 25) 
476 27 133.2 121.5 
 
Figure 4. Localization of major intestinal 
transporters on intestinal skin cells. Rectangles 
with arrows represent transporters. ABC (black) 
and SLC (white) families are designated by color.
1 
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Descriptor Generation 
 Descriptors were generated for each 
dataset using both the open-source 
Chemistry Development Kit (CDK) ver.1.3 
(202 descriptors) as well as Dragon 
ver.1.4.4 (Talete) with explicit hydrogens 
(2489 descriptors). Any descriptors that 
generated an error for at least one 
compound were dropped from the datasets. Descriptors were considered non-informative and 
dropped from individual datasets if they correlated completely with another descriptor or if they 
did not vary across compounds in that 
dataset.  Counts of retained descriptors for 
individual classification and continuous 
datasets are listed in Tables 6 and 7 of the 
appendix and are summarized in Table 2.  
Modelability Index Calculation  
 In a recent publication, Golbraikh et al. proposed the use of a MODelability Index 
(MODI) to assess the goodness of a dataset for successful model building based on the frequency 
of activity cliffs (regions in the descriptor space where chemical activity changes rapidly).
25
 
They offer a definition for classification datasets computed from the number of dissimilar nearest 
neighbors present for each class in the dataset:  
   
(1) 
   
where K is the number of classes, Ni
same
 is the number of compounds belonging to the i
th
 class 
whose nearest neighbor belongs to the same class, and Ni
total
 is the total number of compounds in 
the i
th
 class. Nearest neighbors are determined as the neighbor with the least Euclidean distance 
Table 2. Summary of descriptors retained. 
Descriptor Set  Max Min Mean St. Dev. 
CDK 162 127 151.6 8.4 
Dragon 1420 835 1098.3 135.9 
 
                   
 
 
∑
  
    
  
     
 
 
 
 
Figure 5. Distribution of the characterizations 
of datasets in the database. Note the bias 
towards inhibition datasets, especially among 
continuous datasets.
 
 Analysis and QSAR Modeling of Human Intestinal Transporter Database  
Tkacik, T. J. 12 April 25, 2014 
from the compound in the entire descriptor space.
25
 Because descriptors are generated from the 
chemical structure, the nearest neighbor will be the most structurally similar compound. 
I offer a similar definition of MODI for continuous datasets for use and evaluation in this 
study: 
 
(2) 
 
where N is the total number of compounds, z(ai) is the normalized activity of the i
th
 compound, 
and z(  
 ) is the normalized activity of the neighbor nearest to the i
th
 compound. Therefore MODI 
is calculated as the average number of standard deviations in activity between nearest neighbors.  
 MODI values were computed for each transporter dataset using Python ver.2.7.6 
including the packages NumPy and scikit-learn 
ver.0.14. Descriptors were auto scaled before 
calculating neighbor distances. MODI values 
for individual classification and continuous 
datasets are listed in Tables 6 and 7 of the 
appendix and are summarized in Table 3. 
QSAR Modeling  
 Quantitative structure-activity relationship (QSAR) predictors were created using the 
Carolina Cheminformatics Workbench (Chembench) developed by the Carolina Exploratory 
Center for Cheminformatics Research (CECCR) and according to the workflow outlined in 
Figure 3.
26
 Random forests (RFs) were generated using the randomForest package for R ver.4.6-
7, support vector machines (SVMs) were constructed using an grid-search built on libsvm, and k-
nearest neighbors (kNN) predictors were prepared using an internally developed KNN+ ver.2.82. 
Meta-parameters for each predictor type were controlled across datasets.  
Datasets were split into five equal folds for external cross-validation. Separate predictors 
were generated and evaluated for each external fold and then consolidated into a single 
consensus predictor. Internal test sets were selected by sphere exclusion for datasets with fewer 
than 300 compounds and randomly otherwise. Predictors were created for each dataset using 
either CDK or Dragon descriptor sets. 
               
 
 
∑| (  )   (  
 )|
 
 
 
 
Table 3. Summary of dataset modelability indices. 
Activity Type  Max Min Mean St. Dev. 
Classification 
(N = 31) 
0.98 0.39 0.75 0.11 
Continuous   
(N = 25) 0.58 0.06 0.31 0.13 
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 Continuous datasets were modeled using RF, SVM, and kNN. The kNN predictors were 
trained using a genetic algorithm (GA-kNN) for datasets with greater than 150 compounds and 
both GA-kNN and simulated annealing (SA-kNN) otherwise. Descriptors were normalized using 
range scaling. Predictors were evaluated by the average coefficient of determination (R
2
) of the 
five folds: 
  
(3) 
 
where yi is the observed activity of the i
th
 compound, ŷi is the predicted activity of the i
th
 
compound, and ȳ is the average activity of all compounds.15 Note that because the model 
predictions are not a linear best fit, the sum of squared errors (SSE) may be greater than the total 
sum of squares (SST) in the observed activities. 
Therefore R
2
 values may be negative.
17
 Coefficients 
of determination for individual regression 
predictors, reported as the mean of five cross-
validation folds, are shown in Table 9 of the 
appendix and are summarized in Table 4. 
 As will be shown, modeling technique was not found to have a significant effect on 
predictive power. Therefore, because of its rapid modeling time, classification datasets were 
modeled using RF only. Four predictors were generated for each dataset corresponding to each 
combination of range or auto scaled CDK or Dragon descriptors. Predictors were evaluated by 
the overall correct classification rate (CCR) of the five folds: 
 
(4) 
 
where K is the number of classes (K = 2 for binary datasets), Ni,correct is the number of correctly 
classified compounds in the i
th
 class, and Ni,total is the total number of compounds in the i
th
 class. 
Previous studies have identified a CCR of 0.7 to 
be the threshold for acceptable predictive 
power.
15,25
 CCR, reported as the mean of five 
cross-validation folds, are shown in Table 10 of 
the appendix and are summarized in Table 5. 
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Table 4. Summary of coefficients of 
determination for regression predictors. 
 
Max Min Mean St. Dev. 
R
2
 0.82 -0.20 0.37 0.22 
 
Table 5. Summary of correct classification 
rates for classification predictors. 
 
Max Min Mean St. Dev. 
CCR 0.96 0.48 0.79 0.09 
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Model Fortification 
 Predictors were subjected to several additional thresholds throughout the modeling 
process to maximize predictive power. Datasets with fewer than 30 compounds were not 
modeled (N = 2). Individual models were required to present a squared leave-one-out cross-
validation correlation coefficient (Q
2
) of at least 0.6 to be accepted.  
In addition, stochastic models were identified using y-randomization. This process 
randomly redistributes activities to the compounds in the modeling set, constructs a predictor, 
and calculates a CCR or R
2
 using a fraction of the modeling set as an evaluation set. Five y-
randomized predictors are constructed in this way such that a one-tailed t-test could be conducted 
to determine the probability of obtaining the CCR or R
2
 of the true-activity predictor with 
randomized values. If the p-value was greater than 0.05, the models built using the real data were 
deemed unreliable and rejected. 
An applicability domain (AD) of 0.5 standard deviations was also applied to each model 
of kNN predictors. The standard deviation in Euclidean distance in the descriptor space between 
each compound and its k nearest neighbors was calculated. Models were ignored during 
prediction and evaluation if the new compound did not have at least k neighbors within 0.5 
standard deviations. 
In all, 274 predictors passed all cut-offs. The five datasets with fewer than 50 compounds 
(N = 5) failed to produce any kNN models that passed all cut-offs. In addition, two datasets with 
51 compounds failed to generate adequate models for a single kNN predictor each. 
Statistical Analysis 
 Dataset characterization data and predictor quality data were prepared for analysis using 
Excel ver.14.0 (Microsoft). Statistical analyses were conducted using Stata ver.13.0 (StataCorp). 
Results and Discussion 
A series of linear regression analyses were conducted to reveal correlations between the 
biological, chemical, and numerical characteristics of the datasets and the modelability as 
expressed by the coefficient of determination (R
2
) or correct classification rate (CCR) of the 
predictor. These results may be used to improve future QSAR studies as well as to identify 
relevant properties of the transporter pharmacophores that have not previously been described. 
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Quantifying Predictive Power 
 The coefficient of determination (R
2
) calculated for continuous predictors is a measure of 
the sum of squares of the external validation. Unfortunately, this value does not lend itself well 
to linear regression. In addition, some values of R
2
 were found to be negative. Therefore a 
transformed root of squares (R
1
) was used for analysis: 
 
(5) 
 
where R
2
 is the coefficient of determination. 
 Although it may be tempting to make conclusions about the relative success of regression 
and classification QSAR predictors, it should be emphasized that R
1
 (equations (3) and (5)) and 
CCR (equation (4)) are distinct evaluation measures that are not comparable. Both R
1
 and CCR 
asymptotically approach 1.0 as external prediction improves. However, while R
1
 ranges to 
negative infinity, CCR has a minimal value of zero. A random assignment of regression 
predictions from the observed distribution will result in an R of 0.0, but a random classification 
will result in a CCR of the inverse of the number of classes (CCR = 0.5 for binary data sets). 
Therefore all analyses were conducted separately on either regression or classification predictors.  
Numerical Characteristics 
 Not surprisingly, the size of a dataset was found to have a significant positive correlation 
(p < 0.001) with predictive power for both regression and classification datasets. Furthermore, 
this correlation is best realized when the dataset size is represented by the logarithm of the 
cardinality. Figures 6 and 7 plot the R
1
 values for each regression predictor and CCRs for each 
classification predictor, respectively, against the size of the original dataset.  
     √     
Figure 6. Correlations between the logarithm of the number of compounds and the R
1
 of regression 
predictors. CDK (circles) and Dragon (triangles) descriptors are denoted by shape. RF (green), SVM 
(blue) and kNN (orange) are denoted by color. 
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In addition, QSAR modeling technique, descriptor type, and descriptor scaling are 
denoted for each datum in Figures 6 and 7. None of these characteristics, nor the number of 
descriptors, had a statistically significant effect on predictive power for either continuous or 
classification datasets when controlling for the size of the dataset. 
Modelability Indices 
Classification MODI 
 The definition of a Modelability Index (MODI) offered by Golbraikh et al.
25
 and 
presented again here as equation (1) was found to be a strong indicator of the predictive power of 
RF classification transporter datasets. A significant correlation (R
2
 = 0.72) was found between 
MODI and a predictor’s external CCR. Figure 8 is a plot of each predictor’s CCR against the 
MODI of its original dataset. Using the threshold for modelability also offered by Golbraikh et 
al. (CCR > 0.7), MODI can be used to reliably estimate whether a dataset may yield an 
acceptable predictor. Nearly all (N = 107 of 112) predictors built from datasets with MODI 
above 0.64 resulted in a CCR greater than 0.7. 
In addition, descriptor type, and by extension the number of descriptors, was not found to 
affect the MODI of a dataset. Figure 8 is a plot of the MODI calculated using Dragon descriptors 
versus the MODI calculated using CDK descriptors for each classification dataset. A significant 
correlation (R
2
 = 0.77) was determined for a linear regression through the origin. Note that only 
two datasets deviate from this trend: datasets 41 and 40 located in the lower left of Figure 9. The 
discrepancy in MODI implies that the compounds in these datasets are represented differently in 
some significant way in the different descriptor spaces. These datasets are both concerned with 
R² = 0.2059 
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Figure 7. Correlations between the logarithm of the number of compounds and the CCR of 
classification predictors. CDK (circles) and Dragon (triangles) descriptors are denoted by shape. Auto 
scaling is indicated by the presence of a black border. 
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the inhibition of MRP3 at different thresholds. Cross referencing Figure 8 reveals that the MODI 
calculated using Dragon descriptors better predicted the CCR of the resultant predictors. 
Therefore it may be inferred that CDK does not include some key descriptors relevant to MRP3 
inhibition. However, any major conclusions from these datasets should be avoided because they 
contain relatively few compounds (N = 36 and 35).  
In addition, this set of datasets is biased toward modelable datasets. Additional predictors 
with CCR between 0.5 and 0.7 would need to be studied to verify the correlation in the 
unmodelable quadrant of Figure 8.  
y = 0.7238x + 0.2416 
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Figure 8. Correlation between the CCR of classification predictors and the MODI of their original 
datasets. The threshold for modelability is marked at CCR = 0.7 and correspondingly at MODI = 0.63. 
Datasets 40 (red) and 41(orange) are identified from Figure 9. 
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Figure 9. Correlation between MODI calculated using Dragon descriptors and CDK descriptors for 
each classification dataset. Datasets 40 (red) and 41(orange) are identified as significant outliers.  
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Continuous MODI 
 A novel definition for the MODI of continuous datasets was introduced in equation (2). A 
significant correlation (R
2
 = 0.59) was found between values calculated using this definition of 
MODI and a regression predictor’s R1 value. Figure 10 illustrates this relationship with 
descriptor type and modeling technique identified. Using a coefficient of determination of R
2 
> 
0.5 as the threshold for modelability
15
 corresponds to a root of squares of roughly R
1
 > 0.3. 
Therefore I propose a heuristic threshold of MODI > 0.35 to estimate the modelability of 
continuous datasets.  This cutoff deviates from the regression line to increase sensitivity without 
sacrificing precision in this set. 
Biological Characteristics 
 The membrane transporters were divided into homologous groups for additional analysis. 
Because all ABC transporters are related, this process grouped ABC together and SLC 
transporters into subfamilies. A statistically significant correlation was determined between this 
grouping and the predictive power of classification datasets. In particular, predictors concerning 
SLC transporters reported CCRs 0.089 greater (p < 0.001) than ABC predictors, on average. This 
correlation persists when dataset size and MODI are included in the regression. Figure 11 
illustrates the way that ABC predictors evaluated more poorly, even when the original datasets 
computed similar MODI. This indicates that there are additional factors affecting modelability 
y = 0.8386x - 0.0398 
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Figure 10. Correlation between the R
1
 of regression predictors and the MODI of their original 
datasets. The threshold for modelability is marked at R
1 
= 0.3, and a corresponding cutoff is proposed 
at MODI = 0.35. CDK (circles) and Dragon (triangles) descriptors are denoted by shape. RF (green), 
SVM (blue) and kNN (orange) are denoted by color. 
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besides those captured by MODI. This trend may result from the interaction with ATP as the 
energy source or it may indicate that ABC transporters are reliant on the selectivity of multiple 
external binding proteins.  
Additional features characterizing the membrane transporter and activity measure were 
analyzed as well. The location of the transporter in vivo, whether in the basal or apical 
membranes, was not found to be significant for predictive power. Whether the dataset included 
inhibitor or substrate activity data, however, was significant for both classification and regression 
predictors when controlling for dataset size. Curiously, classification inhibitor datasets predicted 
CCR 0.034 less (p = 0.022) than their substrate counterparts on average, but continuous inhibitor 
datasets evaluated with R
1
 0.080 greater (p = 0.007) on average. This discrepancy is not quickly 
explained, and additional research is needed to determine which, if either, correlation is accurate. 
Conclusions 
 Membrane transport proteins are directly responsible for the movement of chemicals into 
and out of each cell, so predicting their interaction with potential drug candidates is an important 
challenge for drug discovery.
1
 Quantitative structure-activity relationship (QSAR) modeling, as 
part of the greater field of cheminformatics, attempts to predict the activity of new compounds 
by comparing their structures with the structures of compounds with known interactions. This 
technique was applied to 56 datasets concerning 14 major human transporters. A modelability 
index (MODI) for chemical datasets of continuous activities was developed to mimic an existing 
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Figure 11. CCR of predictors by homology group: ABC (blue), SLC10 (yellow), SLC15 (orange), 
SLC16 (green), SLC22 (brown), and SLCO (red). 
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MODI for classification datasets as a heuristic device for estimating predictive power. Dataset 
cardinality and MODI were found to have significant effects on predictive power, but modeling 
technique and descriptor type were not. In addition, transporter homology group was found to 
have a significant effect such that ABC datasets modeled more poorly, on average. This suggests 
that the mechanism of substrate selection of ABC proteins is more complex than that of SLC 
proteins. True validation of QSAR predictors requires laboratory experimentation, which was not 
available for this study.
15
 Therefore additional research is needed to confirm the predictive 
powers of each dataset and verify the correlations observed. 
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Appendix 
  
Table 6. Characterization data for continuous datasets.  
Transporter Activity Hot Ligand 
a 
Number of 
Compounds 
Number of Descriptors 
b
 
 
Modelability Index 
c 
CDK Dragon   CDK Dragon 
Substrate Datasets     
ASBT pKm  51 127              878  
 
0.234 0.147 
MDR1 pKm  63 152           1,015  
 
0.226 0.059 
MRP2 pKm  27 148              944  
 
0.081 0.000 
PEPT1 pKm  72 133              845  
 
0.411 0.329 
Inhibition Datasets     
ASBT pIC50 Taurocholate 341 159           1,243  
 
0.565 0.576 
BCRP pIC50 Any 119 155           1,096  
 
0.420 0.394 
BCRP pIC50 Mitoxantrone 46 138              902  
 
0.389 0.452 
BSEP pIC50 Taurocholate 295 160           1,215  
 
0.175 0.166 
MCT1 pIC50 Any 46 142              955  
 
0.114 0.279 
MDR1 pIC50 Any 476 159           1,229  
 
0.378 0.383 
MDR1 pIC50 Calcein AM 116 154           1,119  
 
0.374 0.306 
MDR1 pIC50 Daunorubicin 302 152           1,164  
 
0.364 0.413 
MDR1 pIC50 Vinblastine 48 140              942  
 
0.148 0.167 
MRP1 pIC50 Any 196 151           1,056  
 
0.474 0.391 
MRP1 pIC50 Calcein AM 54 140              943  
 
0.426 0.236 
MRP1 pIC50 Daunorubicin 108 139              951  
 
0.325 0.341 
MRP2 pIC50 Any 103 154           1,138  
 
0.344 0.313 
MRP2 pIC50 DNP-SG 46 145              971  
 
0.466 0.532 
MRP4 pIC50 Any 40 143              987  
 
0.228 0.240 
NTCP pIC50 Taurocholate 75 155           1,099  
 
0.162 0.177 
OATP2B1 pIC50 Any 27 146           1,010  
 
0.412 0.202 
OCT1 pIC50 Any 87 149              981  
 
0.068 0.207 
OCT1 pIC50 Tetraethylammonium 51 148              949  
 
0.196 0.286 
PEPT1 pIC50 Any 272 155           1,149  
 
0.412 0.326 
PEPT1 pIC50 Glycylsarcosine 269 154           1,147  
 
0.408 0.323 
a 
Hot ligands are specified for inhibition datasets. 
b 
Number of descriptors is the count of informative 
descriptors retained from an initial 202 CDK and 2489 Dragon descriptors. 
c
 Modelability indices 
calculated using equation (2). 
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Table 7. Characterization data for classification datasets.  
Transporter Activity 
a
 
Threshold 
(μM) 
Number of 
Compounds 
Number of Descriptors 
b 
 
Modelability Index 
c 
CDK Dragon   CDK Dragon 
Substrate Datasets      
ASBT Substrate                 106                144             1,064  
 
0.906 0.877 
BCRP Substrate                 169                160             1,227  
 
0.722 0.720 
BSEP Substrate                   34                140                924  
 
0.733 0.708 
MCT1 Substrate                   36                138                835  
 
0.694 0.694 
MDR1 Substrate                 567                162             1,347  
 
0.686 0.679 
MRP1 Substrate                 180                160             1,206  
 
0.849 0.817 
MRP2 Substrate                 222                160             1,192  
 
0.736 0.752 
MRP3 Substrate                 100                158             1,075  
 
0.870 0.910 
MRP4 Substrate                 122                159             1,187  
 
0.762 0.713 
MRP5 Substrate                   58                152             1,092  
 
0.776 0.759 
NTCP Substrate                   70                153             1,065  
 
0.786 0.829 
OATP2B1 Substrate                   59                153             1,046  
 
0.649 0.691 
OCT1 Substrate                   82                154             1,124  
 
0.866 0.817 
PEPT1 Substrate                 292                158             1,176  
 
0.807 0.762 
Inhibition Datasets      
ASBT Inhibitor 10                232                159             1,217  
 
0.853 0.780 
BCRP Inhibitor 10                395                162             1,266  
 
0.762 0.762 
BSEP Inhibitor 10                679                162             1,387  
 
0.753 0.740 
BSEP Inhibitor 100                725                162             1,393  
 
0.791 0.763 
MCT1 Inhibitor 10                  68                147             1,028  
 
0.979 0.954 
MDR1 Inhibitor 10             1,585                162             1,420  
 
0.888 0.886 
MRP1 Inhibitor 10                426                158             1,242  
 
0.831 0.814 
MRP2 Inhibitor 10                104                153             1,127  
 
0.721 0.740 
MRP3 Inhibitor 10                  36                154             1,048  
 
0.624 0.405 
MRP3 Inhibitor 50                  35                154             1,061  
 
0.571 0.393 
MRP4 Inhibitor 10                  67                148             1,069  
 
0.641 0.615 
MRP4 Inhibitor 50                  69                148             1,074  
 
0.761 0.783 
MRP5 Inhibitor 50                  37                144             1,030  
 
0.801 0.763 
NTCP Inhibitor 10                127                158             1,171  
 
0.746 0.673 
OATP2B1 Inhibitor 100                114                159             1,122  
 
0.737 0.754 
OCT1 Inhibitor 100                199                159             1,162  
 
0.779 0.806 
PEPT1 Inhibitor 100                  82                141                956  
 
0.659 0.610 
a 
Substrate datasets distinguish substrates from non-substrates, and inhibitor datasets distinguish 
inhibitors from non-inhibitors at the given threshold concentration. 
b 
Number of descriptors is the count of 
informative descriptors retained from an initial 202 CDK and 2,489 Dragon descriptors. 
c
 Modelability 
indices calculated using equation (1). 
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Table 8. Characterization data for each transporter represented in the database. 
Transporter Gene Membrane Direction Superfamily Subfamily Substrate 
MDR1 ABCB1 Apical Efflux ABC MDR Xenobiotics 
BSEP ABCB11 Apical Efflux ABC MDR Bile Acids 
MRP1 ABCC1 Basal Efflux ABC MRP Organic Anions 
MRP2 ABCC2 Apical Efflux ABC MRP Bile Acids 
MRP3 ABCC3 Basal Efflux ABC MRP Organic Anions 
MRP4 ABCC4 Basal Efflux ABC MRP Cyclic Nucleotides 
MRP5 ABCC5 Basal Efflux ABC MRP Cyclic Nucleotides 
BCRP ABCG2 Apical Efflux ABC White Xenobiotics 
NTCP SLC10A1 Basal Influx SLC SLC10 Bile Acids 
ASBT SLC10A2 Apical Influx SLC SLC10 Bile Acids 
PEPT1 SLC15A1 Apical Influx SLC SLC15 Oligopeptides 
MCT1 SLC16A1 Apical Influx SLC SLC16 Monocarboxylates 
OCT1 SLC22A1 Basal Influx SLC SLC22 Organic Cations 
OATP2B1 SLCO2B1 Apical Influx SLC SLCO Organic Anions 
 
 Analysis and QSAR Modeling of Human Intestinal Transporter Database  
Tkacik, T. J. 26 April 25, 2014 
  
 
 
 
Table 9. External validation results (R
2
, %) for transporter regression predictors.  
Trans-
porter 
Hot 
Ligand a 
CDK Descriptors 
 
Dragon Descriptors 
RF SVM GA-kNN b SA-kNN b,c   RF SVM GA-kNN b SA-kNN b,c 
Substrate Predictors               
ASBT  27 ± 16 15 ± 39 failed 32 ± 36  27 ± 20 -2 ± 20 14 ± 39 3 ± 29 
MDR1  -5 ± 17 12 ± 34 -9 ± 58 22 ± 44  2 ± 30 13 ± 13 6 ± 51 25 ± 28 
PEPT1  41 ± 16 23 ± 29 23 ± 24 30 ± 26  23 ± 18 38 ± 17 39 ± 24 45 ± 19 
Inhibition Predictors               
ASBT Tauro. 82 ± 3 80 ± 2 75 ± 9 77 ± 7  79 ± 4 79 ± 3 73 ± 5 81 ± 4 
BCRP Any 53 ± 14 55 ± 8 59 ± 13 51 ± 15  44 ± 7 56 ± 11 60 ± 7 58 ± 8 
BCRP Mitox. 55 ± 25 31 ± 28 failed failed  36 ± 43 54 ± 18 failed failed 
BSEP Tauro. 27 ± 10 7 ± 10 failed ---  30 ± 18 37 ± 12 5 ± 18 --- 
MCT1 Any 21 ± 23 23 ± 35 failed failed  44 ± 16 33 ± 13 failed failed 
MDR1 Any 55 ± 9 51 ± 10 52 ± 6 ---  55 ± 7 57 ± 8 52 ± 7 --- 
MDR1 Calc.-AM 57 ± 15 50 ± 29 55 ± 6 57 ± 6  60 ± 4 59 ± 10 53 ± 9 56 ± 10 
MDR1 Dauno. 57 ± 10 54 ± 11 59 ± 7 ---  61 ± 8 60 ± 9 60 ± 6 --- 
MDR1 Vinbl. 8 ± 55 -12 ± 55 failed failed  12 ± 34 37 ± 27 failed failed 
MRP1 Any 62 ± 7 64 ± 6 61 ± 9 ---  63 ± 5 61 ± 7 59 ± 11 --- 
MRP1 Calc.-AM 44 ± 24 47 ± 36 27 ± 39 60 ± 20  31 ± 21 45 ± 9 46 ± 29 48 ± 8 
MRP1 Dauno. 53 ± 6 54 ± 15 46 ± 11 54 ± 10  49 ± 14 54 ± 5 38 ± 22 50 ± 8 
MRP2 Any 29 ± 25 -8 ± 76 42 ± 19 40 ± 11  19 ± 33 55 ± 14 34 ± 8 41 ± 7 
MRP2 DNP-SG 50 ± 23 41 ± 35 failed failed  45 ± 19 68 ± 30 failed failed 
MRP4 Any 11 ± 27 8 ± 17 failed failed  18 ± 44 12 ± 36 failed failed 
NTCP Tauro. 27 ± 15 -9 ± 14 9 ± 19 9 ± 11  21 ± 14 -20 ± 62 10 ± 14 10 ± 23 
OCT1 Any 34 ± 28 8 ± 41 29 ± 28 34 ± 24  40 ± 20 16 ± 25 33 ± 33 34 ± 30 
OCT1 N(Et)4 41 ± 31 34 ± 8 19 ± 45 26 ± 39  27 ± 36 59 ± 15 failed 36 ± 26 
PEPT1 Any 46 ± 8 47 ± 16 45 ± 1 ---  40 ± 18 39 ± 12 33 ± 19 --- 
PEPT1 Glycyl. 48 ± 8 27 ± 25 29 ± 21 ---  38 ± 13 28 ± 17 33 ± 15 --- 
Results are mean ± st.dev across five cross-validation folds. All regression predictors were creating using 
range scaled descriptors.
 a 
Inhibition datasets are identified by a hot ligand. 
b
 kNN models of datasets with 
fewer than 50 compounds failed to pass required cut-offs. 
c
 kNN-SA models were not created for datasets 
with more than 150 compounds. No models were created for datasets with fewer than 30 compounds. All 
successful models were significantly better than y-randomized models (see Methods). 
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Table 10. External validation results (CCR, %) for classification transporter predictors.  
Transporter 
Threshold 
a 
(μM) 
CDK Descriptors 
 
Dragon Descriptors 
Range Auto   Range Auto 
Substrate Predictors        
ASBT  87 ± 7 88 ± 7  88 ± 9 87 ± 9 
BCRP  79 ± 3 75 ± 3  73 ± 4 75 ± 3 
BSEP  62 ± 19 68 ± 22  73 ± 18 68 ± 16 
MCT1  79 ± 13 76 ± 12  76 ± 12 79 ± 8 
MDR1  72 ± 3 72 ± 3  74 ± 5 72 ± 5 
MRP1  83 ± 5 85 ± 5  85 ± 7 86 ± 5 
MRP2  79 ± 3 79 ± 4  81 ± 5 80 ± 7 
PEPT1  86 ± 5 86 ± 5  86 ± 5 86 ± 5 
MRP3  89 ± 4 87 ± 7  92 ± 5 91 ± 6 
MRP4  75 ± 11 76 ± 9  75 ± 12 75 ± 13 
MRP5  76 ± 16 69 ± 18  74 ± 12 76 ± 16 
NTCP  89 ± 4 89 ± 6  86 ± 11 83 ± 8 
OATP2B1  73 ± 17 71 ± 9  77 ± 13 81 ± 7 
OCT1  85 ± 11 87 ± 13  85 ± 6 86 ± 8 
Inhibition Predictors        
ASBT 10 88 ± 5 89 ± 5  87 ± 7 87 ± 5 
BCRP 10 81 ± 7 79 ± 7  80 ± 5 82 ± 8 
MCT1 10 96 ± 5 96 ± 5  93 ± 8 91 ± 7 
BSEP 10 83 ± 3 83 ± 3  84 ± 2 84 ± 2 
BSEP 100 77 ± 4 77 ± 5  76 ± 3 77 ± 5 
MDR1 10 91 ± 2 91 ± 2  91 ± 1 91 ± 2 
MRP1 10 84 ± 3 84 ± 4  83 ± 5 83 ± 4 
MRP2 10 79 ± 6 78 ± 11  80 ± 7 81 ± 9 
MRP3 10 61 ± 15
 
56 ± 14  60 ± 20 63 ± 16 
MRP3 50 48 ± 23 54 ± 15  53 ± 21 57 ± 18 
MRP4 10 78 ± 5 73 ± 9  70 ± 11 69 ± 6 
MRP4 50 75 ± 17 73 ± 10  76 ± 12 73 ± 11 
MRP5 50 73 ± 20 78 ± 18  72 ± 17 70 ± 21 
NTCP 10 78 ± 6 79 ± 8  76 ± 9 80 ± 8 
OATP2B1 100 79 ± 8 83 ± 7  81 ± 10 80 ± 5 
OCT1 100 86 ± 7 86 ± 6  85 ± 7 85 ± 7 
PEPT1 100 70 ± 4 74 ± 11 
 
72 ± 6 69 ± 7 
Results are mean ± st.dev across five cross-validation folds. All classification predictors were creating 
using random forests. 
a 
Inhibition datasets are identified by a threshold concentration. All models 
were significantly better than y-randomized models (see Methods). 
 
